Abstract: A pharmaceutical composition comprising an the detoxified cow urine concentrate with all essential ingredients in capsule with an amount effective for curing ,preventive and enhancing the therapeutic effect of the cow urine is disclosed. The detoxified cow urine concentrate can be a general therapeutic agent.This invention relates to many novel compounds, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising detoxified cow urine concentrate of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by binding to. and modulating the sensitivity of, many receptors in the human system. The present invention relates to a synergistic pharmaceutical composition for the treatment of cancer, said composition comprising pharmaceutically effective amount of a detoxified concentrated cow urine in soft gel capsules also it relates to a process for the detoxification and further concentrate the cow urine without the elimination the essential volatile oils for the preparation of a synergistic pharmaceutical composition useful in the treatment of cancer, and lastly, a method of treating cancer.
Description
Field of Invention
From the ancient period in India, cow's urine has been used as a medicine. In
Veda.cow's urine was compared to the nectar (Rigveda 10.15). In Susrut several
medicinalproperties of cow's urine have been mentioned (45/221). Cow's urine is
known to causeweight loss, and reverse certain cardiac and kidney problems,
indigestion, stomach ache.edema, etc. The medicinal properties of cow's urine
have also been mentioned in Charak (sloka-100) where it is considered useful in
treating renal colic, jaundice, anemia, diarrhea.gastric infection, piles and skin
diseases including vitilago. It is also considered as anappetizer and is known to
reverse inflammation, or a diuretic as well as a nephroprotectiveagent.
Ayurveda describes Gomutra as a very holy Rasayana (health tonic) that is capable
of balancing all three dosha (Vata. Pitta and Kapha). As per recent scientific
research findings it contains variety of many useful bio-active substances like
essential amino acids, enzymes, proteins, vitamins, hormones and minerals.
During various scientific studies, it has shown very strong anli bacterial, anti viral.
immuno-stimulator and adaptogenic properties. It also has an ability to enhance
properties of medicinal substance. According to researcher cow urine is a rich
source of various vitamins, minerals and acids. It contains Vitamin A. B. C. I). 1..
Carbolic acid. Uric acid. Sodium. Potassium. Urea. Nitrogen. Phosphate.
Manganese. Iron. Copper. Gold salt and other useful components that are rare
elsewhere.
The invention relates to an absolutely novel use of detoxified concentrated cow
urine in soft gel for the treatments well as prevention of a disease or condition
selected from primary hyperparathyroidism, secondary hyperparathyroidism,
kidney disease, hypophosphatemic rickets, anemia, hypercalcemia, end stage renal
disease, calcification, cardiovascular disease, nephrology. Paget's disease.
osteoporosis, hypertension, and renal osteodystrophyand activity enhancer and
availability facilitator for other bioactive molecules including anti-infective and
anti-cancer agents. The molecules of detoxified concentrated cow urine express
their activity in form of either inhibiting or promoting a biological function have
been referred in this invention as bioactive molecule e.g. herbal drugs,
nutraceuticals. cardiovascular, hepatoproteetive. neuro-tonics etc. The present
invention has proposed the novel therapeutic agent for the improvement of qualit}
of life and increasing the efficiency of absorption of bioactive molecules of herbs.
BACKGROUND OF THE INVENTION
In Ayurveda urine is suggested for improving general health. Among the all urine
cow urine was considered as beast urine for the good health. Tablet, distilled,
fermented forms of cow urine are available only in the market. Presenth the
distillate called as ark or redistilled ark is used in cow urine therapy but it was is
found in our experiments that during distillation the heat degrades the man}
essential amino acids and enzymes. These amino acids, enzvmes and non volatile
nutrients is responsible for the all observed therapeutic effect.
The applicants have developed the curiosity about the component in the all the
cow urine preparations presently available in the market. The applicants was found
great difference in the composition of raw urine and other cow urine preparations
such as, ark or redistilled ark etc.
B. Said et. al (1990) reported the analysis and heat stability of taurine in cow milk.
They developed the method based on formation of the fluorescamine derivative of
taurine and HPLC was developed for analysis of taurine in milk. Taurine in milk
ranged from 2.4 to 12.0 mg/1 . The degradation of taurine in taurine-fortified milk
and in a buffered taurine and lactose solution at pH 6.7 was determined by heating
at 80,100. and 120°C. First-order reaction kinetics was observed for taurine losses
in milk and buffered solution. Activation energies were 20.5 and 21.0 kcafmol for
milk and buffered solution, respectively the taurine loss in milk seems to proceed
through browning with the same degradation rate as lysine.
The detoxified concentrated cow urine in soft gel is suggested for the human
consumption as supplement as recommended b\ the hi an optimal action
directive 2002 46 IC to full fill the basic bod) requirement
The composition of detoxified concentrated cow urine in soft gel as \inmm^
(\itamins A. Ml. B2. B3. B5. IJ6. B8. 1*9. HI 2. C. 1)3. 1;) and minerals (Mu. /n.
Cu. Vln. and minerals for Su. Se. I e. Mo. I. Yi . 2-amino ethane sulfonic acid .is
nonessential amino acid synthesized from the essential amino acid methionine and
works as a neuromodulator or membrane-active amino acid. Niacin as enzvmes
in a base of vegetable oil for the improvement of general health and sold and
distributed
S. Ambwani et. al (2006) reported the medicinal role of the cow urine has been
known since ancient times in India. It has been used to treat various
diseases/disorders related to stomach, kidney, skin etc. It is also reported to ha\e
anti-cancer and immunomodulatory properties. Considering the immunosuressivc
effects of pesticides and immunopotentiating properties of cow urine, the present
stud> evaluated the immunomodulatory properties of cow urine on dimelhoate
induced immunotoxicity in avian lymphocytes using lymphocyte proliferation
assay. Avian lymphocytes showed marked decrease when treated with thousand
times dilution of No Observable Effect Level (NOHL/101) dose of dnnethoate
while significant increase was observed in cow urine treated cells in case of both B
and T cell histogenesis. When exposed to combination treatments of NOHL/Uf
dose of dimethoate and the cow urine, there was a significant increase in both B
and T cell histogenesis as compared with the dimethoate treated cells.
Most of the anti-cancer drugs have serious disadvantages and drawbacks too. Themay present a high degree of toxicity for cells of normal bod\ structures causing,
for example, liver and kidney damages.
The disadvantages and drawbacks may considerably limit the use of available anticancer
drugs. Indeed, often a curative effective dose of the drug can not be given
to a patient due to the too high toxicity of the drug to normal cells or to the too
high degree of discomfort caused to the patient by the drug.
The present invention was the result of planned experiments to provide a novel
method for improving activit)' and bioavailability of anti-cancer drugs, other
molecules using ' detoxified concentrated cow urine ' in different formulations.
16
The bioavailability of nutrients and enhancement antibiotics effect is relevant to
human, plant as well as animal health and thus the compositions and methods of
the invention are also intended to be used in agriculture and veterinarv practice.
DESCRIPTION OF RELATED ART
Cow's urine (Go-mutra) can be considered as the most effective animal origin
substance/secretion with the capacity of general health improvement but it does
need substantiation through scientific experimentation. Thus, the applicants
considered it worthwhile to scientifically look at this and define the molecular
basis of the values through various analytical experiments. The applicants in the
first instance proved that all the cow urine preparation i.e Tablet, distilled, and
fermented forms of cow urine are the onh available in the market. 1 ablet.
distilled, and fermented forms of cow urine are incomplete and these formulation
of cow urine was manufactured under the heat, hence during distillation or
concentrating the heat degrades the many essential amino acids, enzymes and
other heat sensitive micronutrients. No prior arts are available for the
detoxification of cow urine and concentrating the urine without heat treatment and
use in soft gel capsule.
OBJECTS OF THE INVENTION
The main objective is to provide novel use of the cow urine in soft gel capsule.
In another objective of the invention is to provide method to minimize the
essential ingredient loss during concentrating the cow urine.
Still another objective of the invention is to provide a process for the.
detoxification of raw cow urine, concentrating the detoxified of cow urine and
emulsification of concentrated cow urine in a ba so ol \euetablc oil and ninkniLi o!
soft gel capsule form detoxified cow urine concentrate .
Specification of Indian Cow for the collection of urine
The entire urine sample was taken from the native Indian cow.
1. which has hump on her back.
2. and long fan shaped skin
3. Flap below neck. This is the identification of native Indian cow. We believe
that hump serves as a pyramid and absorbs cosmic rays from the universe.
Dated day of JUL 2009
Claims
What is claimed is:
1. A pharmaceutical composition comprising a detoxified cow urine
concentrate in an amount effective to cure, prevent and enhancing the
quality of life in humans.
2. The composition as claimed in claim 1. wherein the one soft gel capsule is
made out by concentrating the 100 milliliter of detoxified cow urine is a
therapeutic agent.
3. The composition as claimed in claim 2. wherein the carbolic acid is one of
the bioactive principle in the soft gel of detoxified cow urine concentrate
use as germicide.
4. The composition as claimed in claim 2. wherein the Vitamin K in O.Oul
ul/ml to 100 fil/ml concentration is one of the bioactive principle in the soft
gel of detoxified cow urine concentrate and involved in the blood clotting
process and in the maintenance of strong bones.
5. The composition as claimed in claim 2. wherein the lactose in 0.001 ulnil
to 100 uJ/mi concentration is one of the bioactive principle in the soft gel of
detoxified cow urine concentrate beneficial for heart and brain disorders.
6. The composition as claimed in claim 2. wherein the Gold salts in 0.01 ul/ml
to 100 |il/ml concentration is one of the ke\ bioactive principle in the soft
gel detoxified cow urine concentrate beneficial for anti aging .
7. The composition as claimed in claim 2. wherein the 2-
aminoethanesulfonic acid in 0.001 jul/ml concentration is one of most rare
bioactive principle in the soft gel of detoxified cow urine concentrate
which is beneficial as neuromodulator and membrane-active amino acid
that helps the cell to hold onto potassium. In the central ncnous sxstem.
taurine has been known as a neuroinhibitory neuromodulator that works
along with gamma-aminobutyric acid (GABA), glycine, and glutamine.
8. The composition as claimed in claim 2. wherein the Oxolinic acid is in
0.01 (il/ml to 100 |il/ml concentration one of the bioactive principle in the
soft gel of detoxified cow urine concentrate it work as antibiotic by
inhibiting the enzyme DNA-gyrase. It also acts as a dopamine reuptake
inhibitor and has stimulant effects in mice
9. The composition as claimed in claim 2. wherein the cthanamine is in 0.01
j-il/ml to 100 |il/ml concentration also one of the key bioaethe principle in
the soft gel of detoxified cow urine concentrate which belogs to the
alkenylene or alkynylene group of 10 carbon atoms and have been found to
possess anti-obesity and/or anti-hyperglycaeinic activity.
10.The composition as claimed in claim 2. wherein the Copper (Cu) is in 0.01
uJ/ml to 100 fil/ml concentration also one of the key bioactive principle in
the soft gel of detoxified cow urine concentrate, presence oi' Copper salts
protects body against diseases
11.The composition as claimed in claim 2, wherein the Nitrogen (N2) is in
0.01 u.l/ml to 100 ul/ml concentration also one of the bioactive principle in
the soft gel of detoxified cow urine concentrate, presence of N2 removes
blood abnormalities and toxins. Natural stimulant of urinan. track, activates
kidneys and it is diuretic.
12.The composition as claimed in claim 2. wherein the Ammonia (NH:,) is in
0.001 ul/ml to 100 ul/ml concentration also one of the bioacthe principle
in the soft gel of detoxified cow urine concentrate, presence of NPh
Stabilize bile, mucous and air of body and blood formation and further
reduces the acidic contents of blood.
13. The composition as claimed in claim 2. wherein the Iron (Fe) is at 8 mg/ml
concentration also one of the bioactive principle in the soft gel o\'
detoxified cow urine concentrate, presence of NH? Stabilize bile, mucous
and air of body and blood formation.
14.The composition as claimed in claim 2. wherein the Uric Acid (C\R|N4Ch)
is at 8 mg/ml concentration also one of the bioactive principle in the soli
gel of detoxified cow urine concentrate, prevents the swelling of heart and
other inflammations.
15.The composition as claimed in claim 2. wherein the Phosphate (P) is at 8
jug /ml concentration one of the bioactive principle in the soft gel of
detoxified cow urine concentrate, prevents the swelling of heart and other
inflammations.
16.The composition as claimed in claim 2. wherein the Sodium (P) is at 2 ug
/ml concentration one of the bioactive principle in the soil gel of detoxified
cow urine concentrate, work as antacid and prevents Purifies blood.
17. The composition as claimed in claim 2. wherein the Potassium is at 5
|ig/ml concentration one of the bioactive principle in the soft gel of
detoxified cow urine concentrate. Cures hereditary rheumatism and
removes muscular weakness and laziness.
18.The composition as claimed in claim 2, wherein the Manganese (Mn) and
Calcium Ca (P) is at 2 jig /ml concentration one of the bioactive principle in
the soft gel of detoxified cow urine concentrate, work as Blood purifier and
bone strengthener.
19.The composition as claimed in claim 2. wherein the Vitamin A (800 ug).
Vitamin D10 ug. Vitamin E 40 mg. Vitamin CI50 mg. Bl 18 mg. B2 6mg
B3 27 mg. B6 lOmg. B1214 ug. Pantothenic Acid 20 mg. Carotenoids at 30
mg to 800 (.ig /ml as other essential principles for energy and increase
concentration, mental alertness, sharp perceptions and stimulates
metabolism also saves from nervousness and thirst, and increase
reproductive and immunity power.
20. The composition according to claim 19. wherein the therapeutic agent is
selected from vitamin D. a vitamin D analogue, a phosphate binder, and an
agent used to raise serum calcium concentrations.
21. The composition as claimed in claim 2. wherein the 3,4-
Dimethylpentanol is 0.01 ul/ml to 100 pl/ml concentration one of the
bioactive principle in the soft gel of detoxified cow urine concentrate
which have strong Antimicrobial activity with a MIC value of 31.5 mcg/ml.
22. The composition as claimed in claim 1. wherein detoxified cow urine
principles of cow urine was concentrated by high throughput vacuum
evaporator.
23. The composition as claimed in claim 1 to 12. wherein the detoxified cow
urine concentrate has the following physical characteristics: a pale yellow
color, a solid crystalline form, water solubility, and an all the retention
values was taken in triplet and all the bioactive principles was characteri/ed
by MS(N1ST 2008 and other relevant reference ).
24.The composition according to claim 2. wherein the composition is
formulated for pharmaceutical use and the carrier is a pharmaceutical!)
acceptable carrier.
25. The composition according to claim 24. wherein the composition is
formulated for oral use.
26. The composition according to claim 24. wherein the composition is used
for the treatment or prevention of a disease or condition selected from
primary hyperparathyroidism, secondary hyperparathyroidism. kidncdisease, hypophosphatemic rickets, anemia, hypercalcemia, end stage renal
disease, calcification, cardiovascular disease, nephrology. Paget's disease,
osteoporosis, hypertension, and renal osteodystrophy.
27. The composition according to claim 25. wherein the composition is used
for the treatment of polymorphonuclear leukocytes with H202
andactinomycin-D along with the detoxified cow urine concentrate of
cow's urine showed 70%-80% protective effects (/><().()() 1) in
Fluorimetric Analysis of DNA Unwinding .
28.The method accordins to claim 26. wher ein the disease or condition is
selected from secondary hyperparathyroidism and hypercalcemia.
29.The method according to claim 28. wherein the antigenotoxic'aniioxidani
properties of detoxified cow urine concentrate were studied in vitro. 1 he
antioxidant status and volatile fatty acid levels were also determined.
30. The method according to claim 29. wherein the fatty acid concenlration
was 1500 mg/L in detoxified cow urine concentrate were which work as
potent antioxidant
31.The method according to claim 2. wherein the subject is a human.
| # | Name | Date |
|---|---|---|
| 1 | 1542-del-2009-abstract.pdf | 2011-08-21 |
| 1 | 1542-del-2009-form-2.pdf | 2011-08-21 |
| 2 | 1542-del-2009-form-1.pdf | 2011-08-21 |
| 3 | 1542-del-2009-description (complete).pdf | 2011-08-21 |
| 4 | 1542-del-2009-claims.pdf | 2011-08-21 |
| 5 | 1542-del-2009-abstract.pdf | 2011-08-21 |